Results 81 to 90 of about 34,497 (254)

Research Trends in Telogen Effluvium From 1975 to 2025: A Bibliometric Analysis

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Telogen effluvium (TE) is a common cause of diffuse hair loss. Bibliometric analyses systematically map research trends to identify influential studies and reveal knowledge gaps. Objectives To characterize research trends, influential publications, and knowledge gaps in the telogen effluvium literature through bibliometric analysis ...
Katya Peri, Eric McMullen, Megan Park, Narachai Julanon, Jeffrey Donovan, Cathryn Sibbald   +5 more
wiley   +1 more source

Spironolactone improves Angiotensin-induced vascular changes and oxidative stress

, 2002
Angiotensin II plays an important role in vascular remodeling. We investigated the role of aldosterone, which is stimulated by angiotensin II, as a mediator of angiotensin II–induced vascular structural and functional alterations.
Touyz, R.M., Amiri, F., Viel, E., Ernesto L. Schiffrin, Agostino Virdis, Schriffin, E.L., TOUYZ RM, NEVES MF, Rhian M. Touyz, SCHIFFRIN E.L., VIRDIS, AGOSTINO, Farhad Amiri, Virdis, A., Neves, M.F., VIEL E, Mario Fritsch Neves, Emilie Viel, AMIRI F   +17 more
core   +1 more source

Integrative Approaches in Cardiovascular Disease: The Role of Nutraceuticals in Heart Failure, Atrial Fibrillation, and Related Conditions

Phytotherapy Research, EarlyView.
Schematic representation of the shared pathophysiological mechanisms underlying heart failure (HF) and atrial fibrillation (AF), including inflammation, oxidative stress, endothelial dysfunction, and fibrosis. The figure highlights the clinical and mechanistic convergence of conventional pharmacological therapies and selected nutraceuticals in ...
Laura Beatrice Mattioli, Ivan Corazza, Roberta Budriesi, Luca Camarda, Maria Carelli, Alberto Spadotto, Igor Diemberger   +6 more
wiley   +1 more source

Safety profile of mineralocorticoid receptor antagonists. spironolactone and eplerenone

, 2015
Spironolactone was first developed over 50 years ago as a potent mineralocorticoid receptor antagonist with undesirable side effects; it was followed a decade ago by eplerenone, which is less potent but much more mineralocorticoid receptor-specific. From
GRECO, Cesare, SCHIARITI, Michele Salvatore Maria, Speziale, Giuseppe, GAUDIO, Carlo, Rosano, Giuseppe, Vitale, Cristiana, PELLICCIA, FRANCESCO, Lainscak, Mitja   +7 more
core   +1 more source

Plant‐derived nanovesicles as potential drug delivery systems for topical use: Emerging applications in dermatology and cosmetology

VIEW, EarlyView.
Plant‐derived nanovesicles (PDNVs) are naturally secreted by fruit, vegetables, seeds, leaves and other natural sources. Used as drug delivery systems, they can combine intrinsic therapeutic activity, enhanced skin permeation and cargo‐carrying capacity, suitable for dermatological and cosmetic applications including hydration, antioxidant/anti ...
Dorotea Fiore, Beatrice Pellegrini, Antonia Mancuso, Maria Chiara Cristiano, Salvatore Panza, Donatella Paolino   +5 more
wiley   +1 more source

Anti-Fibrosis Effect of Relaxin and Spironolactone Combined on Isoprenaline-Induced Myocardial Fibrosis in Rats via Inhibition of Endothelial–Mesenchymal Transition

Cellular Physiology and Biochemistry, 2017
Background: The effect of relaxin and spironolactone combined on myocardial fibrosis has not been reported. Thus, we investigated the effect of the combined therapy on isoprenaline-induced myocardial fibrosis and the mechanism.
Jiejie Cai, Xiao Chen, Xingxing Chen, Lingzhi Chen, Gaoshu Zheng, Hao Zhou, Xi Zhou   +6 more
doaj   +1 more source

Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia

, 2014
Rehab Nabil Shamma, Mona Hassan AburahmaDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, EgyptAbstract: Spironolactone (SL) is a US Food and Drug Administration-approved drug for the treatment of ...
Shamma RN, Aburahma MH
core  

The acute effects of different spironolactone doses on cardiac function in streptozotocin-induced diabetic rats

, 2017
Currently, cardiovascular diseases are the leading cause of global mortality, while diabetes mellitus remains an important cause of cardiovascular morbidity.
Stefan Simovic, Vladimir Zivkovic, Ivan Srejovic, Aleksandra Vranic, Vladimir Jakovljevic, Petar Ristic, Isidora Stojic, Tamara Nikolic, Dusan Djuric   +8 more
core   +1 more source

Hormone Replacement Therapy for Menopausal Symptoms and the Risk of Cardiometabolic Disease: Current Evidence and Future Directions

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background The transition through menopause is accompanied by a series of adverse metabolic changes which are associated with an increased risk of cardiometabolic disease, a major cause of mortality in women after midlife. Whilst the indication for menopausal hormone replacement therapy (HRT) is the control of menopausal symptoms ...
Jiawen Dong, Sarah Hillman, Sharon Dixon, Anupa Shah, Radha Venkatakrishnan, Jeremy W. Tomlinson   +5 more
wiley   +1 more source

Indications and Efficacy of Progestogen‐Monotherapy as Menopause Hormone Therapy: A Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms (VMS) and other manifestations of menopause; however, its use is limited in women with contraindications to oestrogen. Progestogen monotherapy, though historically underutilized, represents a viable alternative in this population. This narrative review
Chloe Thomas, Olivia Carere, Lauren Clarfield, Michelle Jacobson   +3 more
wiley   +1 more source